(Q43269917)

17 November 2017

Pathology and molecular biology of gastrointestinal stromal tumors (GIST) (English)

1 reference

17 November 2017

1 reference

H-U Schildhaus

1

1 reference

17 November 2017

S Merkelbach-Bruse

series ordinal

2

1 reference

17 November 2017

R Büttner

series ordinal

3

1 reference

17 November 2017

E Wardelmann

series ordinal

4

1 reference

17 November 2017

language of work or name

German

0 references

publication date

1 December 2009

1 reference

17 November 2017

1 reference

17 November 2017

49

1 reference

17 November 2017

12

1 reference

17 November 2017

1104-1108

1 reference

https://scigraph.springernature.com/pub.10.1007/s00117-009-1850-y

17 November 2017

0 references

cites work

KIT mutations are common in incidental gastrointestinal stromal tumors one centimeter or less in size

1 reference

https://api.crossref.org/works/10.1007%2FS00117-009-1850-Y

Mutations in exons 9 and 13 of KIT gene are rare events in gastrointestinal stromal tumors. A study of 200 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00117-009-1850-Y

KIT extracellular and kinase domain mutations in gastrointestinal stromal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00117-009-1850-Y

The complexity of KIT gene mutations and chromosome rearrangements and their clinical correlation in gastrointestinal stromal (pacemaker cell) tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00117-009-1850-Y

Association of platelet-derived growth factor receptor alpha mutations with gastric primary site and epithelioid or mixed cell morphology in gastrointestinal stromal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00117-009-1850-Y

KIT 1530ins6 mutation defines a subset of predominantly malignant gastrointestinal stromal tumors of intestinal origin

21 January 2018

1 reference

12 December 2020

The c-KIT mutation causing human mastocytosis is resistant to STI571 and other KIT kinase inhibitors; kinases with enzymatic site mutations show different inhibitor sensitivity profiles than wild-type kinases and those with regulatory-type mutations

1 reference

12 December 2020

Mechanisms of resistance to imatinib mesylate in gastrointestinal stromal tumors and activity of the PKC412 inhibitor against imatinib-resistant mutants

1 reference

12 December 2020

[Histogenesis of benign pleomorphic mesenchymal tumors]

1 reference

12 December 2020

Risk stratification of patients diagnosed with gastrointestinal stromal tumor.

1 reference

12 December 2020

GISTs with PDGFRA exon 14 mutations represent subset of clinically favorable gastric tumors with epithelioid morphology

1 reference

12 December 2020

[Gastrointestinal stromal tumors carrying PDGFRalpha mutations occur preferentially in the stomach and exhibit an epithelioid or mixed phenotype]

1 reference

12 December 2020

PDGFRA activating mutations in gastrointestinal stromal tumors.

1 reference

12 December 2020

Efficacy of the kinase inhibitor SU11248 against gastrointestinal stromal tumor mutants refractory to imatinib mesylate

1 reference

12 December 2020

Diagnosis of gastrointestinal stromal tumors: A consensus approach

1 reference

12 December 2020

Association of KIT exon 9 mutations with nongastric primary site and aggressive behavior: KIT mutation analysis and clinical correlates of 120 gastrointestinal stromal tumors

1 reference

12 December 2020

c-kit mutations in gastrointestinal stromal tumors occur preferentially in the spindle rather than in the epithelioid cell variant

1 reference

12 December 2020

Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor

1 reference

12 December 2020

Gastrointestinal pacemaker cell tumor (GIPACT): gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal

1 reference

12 December 2020

Gastrointestinal stromal tumours: ESMO clinical recommendations for diagnosis, treatment and follow-up.

1 reference

12 December 2020

Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors

1 reference

12 December 2020

Deletion of Trp-557 and Lys-558 in the juxtamembrane domain of the c-kit protooncogene is associated with metastatic behavior of gastrointestinal stromal tumors

1 reference

12 December 2020

KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours

1 reference

12 December 2020

Gastrointestinal stromal tumors with internal tandem duplications in 3' end of KIT juxtamembrane domain occur predominantly in stomach and generally seem to have a favorable course

1 reference

12 December 2020

Polyclonal evolution of multiple secondary KIT mutations in gastrointestinal stromal tumors under treatment with imatinib mesylate

1 reference

12 December 2020

Acquired resistance to imatinib in gastrointestinal stromal tumours caused by multiple KIT mutations

1 reference

12 December 2020

Gastrointestinal stromal tumors: pathology and prognosis at different sites

1 reference

12 December 2020

Prognosis and predictive value of KIT exon 11 deletion in GISTs

1 reference

12 December 2020

Use of c-KIT/PDGFRA mutational analysis to predict the clinical response to imatinib in patients with advanced gastrointestinal stromal tumours entered on phase I and II studies of the EORTC Soft Tissue and Bone Sarcoma Group

1 reference

12 December 2020

Effect of c-kit mutation on prognosis of gastrointestinal stromal tumors

1 reference

12 December 2020

Deletions affecting codons 557-558 of the c-KIT gene indicate a poor prognosis in patients with completely resected gastrointestinal stromal tumors: a study by the Spanish Group for Sarcoma Research (GEIS).

1 reference

12 December 2020

Monoclonal antibody DOG1.1 shows higher sensitivity than KIT in the diagnosis of gastrointestinal stromal tumors, including unusual subtypes

1 reference

12 December 2020

KIT-negative gastrointestinal stromal tumors: proof of concept and therapeutic implications

1 reference

12 December 2020

KIT activation is a ubiquitous feature of gastrointestinal stromal tumors

1 reference

12 December 2020

Gain-of-function mutations of platelet-derived growth factor receptor alpha gene in gastrointestinal stromal tumors.

1 reference

12 December 2020

A great majority of GISTs with PDGFRA mutations represent gastric tumors of low or no malignant potential

1 reference

12 December 2020

10.1007/S00117-009-1850-Y

Identifiers

DOI

1 reference

17 November 2017

1 reference